NMTC — Neuroone Medical Technologies Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Neuroone Medical Technologies, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	4.04	6.9	11.1	5.32	1.46
Net Total Accounts Receivable
Net Total Receivables	—	0.048	0.033	0	0.177
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	4.16	7.29	12.2	7.31	4.63
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.448	0.512	0.535	0.695	0.672
Net Intangible Assets
Total Assets	4.76	7.94	12.8	8.1	5.37
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	2.36	1.18	3.1	1.79	2.21
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2.69	1.38	3.22	1.85	4.55
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	2.07	6.55	9.6	6.25	0.822
Total Liabilities & Shareholders' Equity	4.76	7.94	12.8	8.1	5.37
Total Common Shares Outstanding